The value of Ga-67 scintigraphy and F-18 fluorodeoxyglucose positron emission tomography in staging and monitoring the response of lymphoma to treatment
- 1 July 2001
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 31 (3), 177-190
- https://doi.org/10.1053/snuc.2001.23519
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Revisiting the prognostic role of gallium scintigraphy in low-grade non-Hodgkin's lymphoma.European Journal of Nuclear Medicine and Molecular Imaging, 1997
- Utility of gallium-67 scintigraphy in low-grade non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1996
- Ga-67 SPECT before and after treatment of lymphoma.Radiology, 1990
- Lymphoma: evaluation with Ga-67 SPECT.Radiology, 1987
- Gallium scintigraphy in American Burkitt lymphoma: accurate assessment of tumor load and prognosisAmerican Journal of Roentgenology, 1985
- High-dose gallium imaging in lymphomaAmerican Journal Of Medicine, 1983
- Gallium-67 scanning: Limited usefulness in staging patients with non-Hodgkin's lymphomaAmerican Journal Of Medicine, 1980
- The relative roles of gallium-67-citrate scanning and lymphangiography in the current management of malignant lymphomaCancer, 1977
- Gallium Citrate Ga 67 ScanningArchives of Internal Medicine, 1976
- Gallium-67 Localization in Rat and Mouse TumorsScience, 1970